Recovery of Functional Memory T Cells in Lung Transplant Recipients Following Induction Therapy with Alemtuzumab

This publication has 23 references indexed in Scilit:

• Assessing Relative Risks of Infection and Rejection: A Meta-analysis using an Immune Function Assay
  Transplantation, 2006
• Combined CMV Prophylaxis Improves Outcome and Reduces the Risk for Bronchiolitis Obliterans Syndrome (BOS) after Lung Transplantation
  Transplantation, 2006
• Clinical impact of ganciclovir‐resistant cytomegalovirus infections in solid organ transplant patients
  Transplant Infectious Disease, 2005
• Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy
  The Journal of Thoracic and Cardiovascular Surgery, 2005
• Immunocompetent T-Cells with a Memory-Like Phenotype are the Dominant Cell Type Following Antibody-Mediated T-Cell Depletion
  American Journal of Transplantation, 2005
• Following Universal Prophylaxis with Intravenous Ganciclovir and Cytomegalovirus Immune Globulin, Valganciclovir is Safe and Effective for Prevention of CMV Infection Following Lung Transplantation
  American Journal of Transplantation, 2004
• RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)
  Transplantation, 2003
• Ganciclovir‐Resistant Cytomegalovirus in Organ Transplant Recipients
  Clinical Infectious Diseases, 2002
• Clinical significance of CMV-specific T helper responses in lung transplant recipients
  Human Immunology, 1998
• PROLIFERATION OF CYTOMEGALOVIRUS-PRIMED LYMPHOCYTES IN BRONCHOALVEOLAR LAVAGES FROM LUNG TRANSPLANT PATIENTS
  Transplantation, 1992